RedHill Biopharma (RDHL) Net Equity Issued and Repurchased (2013 - 2023)
RedHill Biopharma (RDHL) recorded Net Equity Issued and Repurchased of $7.76 million in the year ended Dec 31, 2025, down 6.0% from $8.26 million a year earlier.
Powered by 
Analysis
RedHill Biopharma (RDHL) Net Equity Issued and Repurchased (2013 - 2023) Analysis & Trends
Starting with the year ended Dec 31, 2011, RedHill Biopharma's Net Equity Issued and Repurchased history includes 15 years.
- Annual Net Equity Issued and Repurchased has declined for four straight years, with a five-year compound annual growth rate of -20.1% (years ended Dec 2020 to Dec 2025).
- The figure for the year ended Dec 31, 2025 is the lowest annual Net Equity Issued and Repurchased since the year ended Dec 31, 2013.
- Per Business Quant data, RDHL's Net Equity Issued and Repurchased was $8.26 million in the year ended Dec 31, 2024 (-40.8%), $13.96 million in the year ended Dec 31, 2023 (-41.4%), $23.81 million in the year ended Dec 31, 2022 (-99.4%) and $4.01 billion in the year ended Dec 31, 2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 43.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 6.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 9.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 47.70 Mn |
| 10 | RedHill Biopharma | 7.09 Mn | 7.09 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2023 | -1.61 Mn |
| Mar 31, 2023 | 6.71 Mn |
| Dec 31, 2022 | 7.59 Mn |
| Jun 30, 2022 | 15.51 Mn |
| Mar 31, 2022 | 713,000.00 |
| Dec 31, 2021 | 3.95 Bn |
| Sep 30, 2021 | 665,000.00 |
| Jun 30, 2021 | 273,000.00 |
| Mar 31, 2021 | 57.94 Mn |
| Dec 31, 2020 | 8.37 Mn |
| Sep 30, 2020 | 9.14 Mn |
| Jun 30, 2020 | 6.36 Mn |
| Dec 31, 2018 | 18.35 Mn |
| Sep 30, 2018 | 23.55 Mn |
| Mar 31, 2018 | 355,000.00 |
| Dec 31, 2017 | 20.93 Mn |
| Mar 31, 2017 | 1.28 Mn |
| Dec 31, 2016 | 35.64 Mn |
| Jun 30, 2016 | 100,000.00 |
| Mar 31, 2016 | 10,000.00 |
API Access
RedHill Biopharma Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=RDHL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "RDHL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=RDHL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();